Reuters logo
BRIEF-Ionis Pharmaceuticals announces plans to open expanded access program to provide Inotersen to patients
October 27, 2017 / 11:38 AM / a month ago

BRIEF-Ionis Pharmaceuticals announces plans to open expanded access program to provide Inotersen to patients

Oct 27 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis pharmaceuticals announces plans to open expanded access program to provide Inotersen to patients with hereditary TTR Amyloidosis in the U.S.

* Ionis Pharmaceuticals Inc - on track to complete regulatory filings for market authorization in U.S. and EU before year end, for Inotersen​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below